KPIs & Operating Metrics(New)
Biopharma Testing VolumeBreakdown Of AssetsClinical VolumeContractual ObligationsCost Of RevenueCost Of Revenue By SegmentDeferred RevenueEmployee StatisticsGross Margin %Gross Margin By Segment %Gross ProfitGross Profit By SegmentIncome Before Provision For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProperty And Equipment, NetRevenueRevenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Cost Of Revenue (2017 - 2025)

Historic Cost of Revenue for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $127.4 million.

  • Guardant Health's Cost of Revenue rose 3013.38% to $127.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $456.0 million, marking a year-over-year increase of 3440.71%. This contributed to the annual value of $364.9 million for FY2024, which is 2361.17% up from last year.
  • Per Guardant Health's latest filing, its Cost of Revenue stood at $127.4 million for Q3 2025, which was up 3013.38% from $119.6 million recorded in Q2 2025.
  • Guardant Health's Cost of Revenue's 5-year high stood at $127.4 million during Q3 2025, with a 5-year trough of $34.3 million in Q1 2021.
  • For the 5-year period, Guardant Health's Cost of Revenue averaged around $79.1 million, with its median value being $79.1 million (2023).
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 10015.14% in 2021, then plummeted by 1422.92% in 2023.
  • Guardant Health's Cost of Revenue (Quarter) stood at $59.6 million in 2021, then soared by 36.62% to $81.4 million in 2022, then decreased by 2.82% to $79.1 million in 2023, then skyrocketed by 32.4% to $104.8 million in 2024, then rose by 21.58% to $127.4 million in 2025.
  • Its last three reported values are $127.4 million in Q3 2025, $119.6 million for Q2 2025, and $104.3 million during Q1 2025.